XML 56 R36.htm IDEA: XBRL DOCUMENT v3.22.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2021
Income Tax Disclosure [Abstract]  
Schedule of loss before Income Taxes
For financial reporting purposes, income (loss) before income taxes includes the following components:
Years Ended December 31,
(in thousands)202120202019
United States$(333,571)$(365,332)$(393,955)
Foreign92,017 91,078 38,045 
Total$(241,554)$(274,254)$(355,910)
Schedule of Income Tax Expense (Benefit)
Following were the components of income tax expense (benefit) for the years ended December 31, 2021, 2020, and 2019:
Years Ended December 31,
(in thousands)202120202019
Current
Federal$— $— $— 
State— — — 
Foreign8,857 4,163 2,877 
Deferred
Federal15 (1,410)(984)
State34 (155)(1,415)
Foreign— — — 
Total$8,906 $2,598 $478 
Schedule of Reconciliation of the Statutory Tax Rates and the Effective Tax Rates
A reconciliation of the statutory tax rates and the effective tax rates for the years ended December 31, 2021, 2020, and 2019 are as follows:
Years Ended December 31,
202120202019
Statutory rate(21)%(21)%(21)%
State taxes, net of federal benefit— — — 
Nondeductible IPR&D— — — 
Contingent consideration— — — 
Tax credits(9)(7)(16)
Impact of foreign operations
Nondeductible executive compensation
Nondeductible debt conversion— — (1)
Other— (1)
Valuation allowance28 23 29 
Net%%— %
Schedule of Significant Components of the Deferred Tax Assets and Liabilities The significant components of the deferred tax assets and liabilities are as follows:
Years Ended
December 31,
(in thousands)20212020
Deferred tax assets
Intellectual property$105,453 $68,209 
Amortization/depreciation277 489 
Research tax credit205,095 182,651 
Net operating loss carry forwards334,762 305,876 
Deferred reimbursements1,587 1,912 
Non-cash stock issue11,779 17,553 
Interest carry forward limitation8,285 5,655 
Lease liability9,105 9,235 
Other15,884 10,855 
Gross deferred tax assets692,227 602,435 
Deferred tax liabilities
Business acquisition(4,930)(4,937)
Royalty payable(105,453)(68,209)
Convertible notes— (94)
Advanced R&D payments(1,802)(1,776)
Right of use asset(3,130)(3,420)
Total net deferred tax assets576,912 523,999 
Less: valuation allowance(581,842)(528,895)
Net deferred tax liability$(4,930)$(4,896)